Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

Part of Hansoh Pharmaceutical Group Co., Ltd., Jiangsu Hansoh Pharmaceutical Co. Ltd. is a Chinese company located in Jiangsu. The firm manufactures and distributes pharmaceutical products.

Shanghai Hansen Biomedical Technology Co., Ltd., established on 2011-10-13, Business scope includes biological,Research and development of chemical raw materials and pharmaceutical preparations,technical consulting,Business Consulting,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wuhan Kangxinrui Gene Health Technology Co., Ltd., established on 2013-10-30, The business scope includes life science instruments,Research and development of medical testing instruments and supporting equipment,Production,Sales,Related inquiries,Technical Services;Development of in vitro diagnostic reagents,Production,Sales;software development,Sales,consultation service;technology development,data processing,information analysis,Experimental design service;Operating import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Molecular Machines & Industries (MMI) is the leading provider of microscope-based micromanipulation solutions for the life sciences, material sciences,and healthcare. We specialize in single cell handling, laser microdissection and optical tweezers for a wide range of clinical and research-based applications. MMI is a high-value partner for our customers providing worldwide unique competence in micromanipulation and single cell handling. Founded in 1998 by Prof. Dr. Stefan Seeger in Heidelberg, Germany, MMI moved in 2001 to Zurich, Switzerland. Since then, MMI emerged into the global market and today has established a broad instruments base all over the world.

Biotogether Co. Ltd. develops pharmaceutical intermediates , food additives, animal feed additives, and raw materials used in cosmetics and nutraceuticals. The company was founded in 2005 and is headquartered in Nanjing, China.

Majorbio offers gene sequencing and analysis service. Their cloud platforms gadgets such as limma difference analysis, violin diagram, primer design, pcoa, kegg compound classification, venn analysis, statistical analysis, km survival analysis curve, anti smash, roc analysis line chart, wgcna analysis, and outlier handling.

Neuroprogen GmbH is a biotechnology company that produces medicines for treatment against Parkinson's disease. The company offers in-vivo production of dopamine producing brain cells. Neuroprogen was founded in October 2001 and is based in Leipzig, Germany.

Jilin Aodong Pharmaceutical Industry Group Yanji Co., Ltd. is a pharmaceutical company in China. Its operation includes manufacturing, research & development of pharmaceutical products.The company was founded in September 1998 and is headquartered in Jilin, CN.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Yamasa Corp. manufactures and supplies soy sauce and seasonings. It processes and supplies soy sauce, seasonings, sauces, dips, and flavorings. The firm also develops pharmaceuticals and biochemicals. The company was founded in 1645 and is headquartered in Choshi, Japan.

ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.

Medivir AB engages in the development of pharmaceuticals products. The firm focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipelines such as remetinostat, birinapant, MV-818, MV-828, and MIV-711 projects; and partnership pipeline which covers xerclear and MIV-802 project. The company was founded in 1988 and is headquartered in Huddinge, Sweden.

Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Tianjin Beiyang Baichuan Biotechnology Co., Ltd., established on 2008-05-22, Business scope includes biotechnology research and development,Achievement transfer and related consulting services;Outsourcing services for biotechnology research and development;Pharmaceutical Intermediates,Reagent(except medicines)Sales;Wholesale and retail of prepackaged food(Those involving industry norms shall operate within the validity period with the license);Wholesale and retail of food additives;Chemical raw materials and products(Hazardous chemicals and flammable and explosive precursors are excluded),Rubber products and raw materials,Textile Raw Materials,Sales of plastic products and raw materials;Business Consulting;Machinery and Equipment Leasing(Except finance lease).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)